-
1
-
-
0027501536
-
Pulmonary hypertension in a case of dermatomyositis
-
Grateau G, Roux ME, Franck N, et al. Pulmonary hypertension in a case of dermatomyositis [letter]. J Rheumatol. 1993;20:1452-1453.
-
(1993)
J Rheumatol
, vol.20
, pp. 1452-1453
-
-
Grateau, G.1
Roux, M.E.2
Franck, N.3
-
2
-
-
0030954245
-
The association of malignancy with rheumatic and connective tissue diseases
-
Carsons S. The association of malignancy with rheumatic and connective tissue diseases. Semin Oncol. 1997;24:360-372.
-
(1997)
Semin Oncol
, vol.24
, pp. 360-372
-
-
Carsons, S.1
-
3
-
-
0035125690
-
Dermatomyositis associated with IgG myeloma
-
Borgia F, Vaccaro M, Guarneri F, Cannavo SP, Guarneri B. Dermatomyositis associated with IgG myeloma [letter]. Br J Dermatol. 2001;144:200-201.
-
(2001)
Br J Dermatol
, vol.144
, pp. 200-201
-
-
Borgia, F.1
Vaccaro, M.2
Guarneri, F.3
Cannavo, S.P.4
Guarneri, B.5
-
5
-
-
84939662204
-
Pulmonary hypertension in dermatomyositis
-
Caldwell IW, Aitchison JD. Pulmonary hypertension in dermatomyositis. Br Heart J. 1956;18:273-276.
-
(1956)
Br Heart J
, vol.18
, pp. 273-276
-
-
Caldwell, I.W.1
Aitchison, J.D.2
-
6
-
-
2342528223
-
Polymyositis: Report of two cases with pulmonary function studies suggestive of progressive systemic sclerosis
-
Pace WR Jr, Decker JL, Martin CJ. Polymyositis: report of two cases with pulmonary function studies suggestive of progressive systemic sclerosis. Am J Med Sci. 1963;245:322-332.
-
(1963)
Am J Med Sci
, vol.245
, pp. 322-332
-
-
Pace Jr., W.R.1
Decker, J.L.2
Martin, C.J.3
-
7
-
-
0030028272
-
The role of thrombosis in severe pulmonary hypertension
-
Chaouat A, Weitzenblum E, Higenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur Respir J. 1996;9:356-363.
-
(1996)
Eur Respir J
, vol.9
, pp. 356-363
-
-
Chaouat, A.1
Weitzenblum, E.2
Higenbottam, T.3
-
8
-
-
0019350655
-
Pulmonary hypertension in polymyositis
-
Bunch TW, Tancredi RG, Lie JT. Pulmonary hypertension in polymyositis. Chest. 1981;79:105-107.
-
(1981)
Chest
, vol.79
, pp. 105-107
-
-
Bunch, T.W.1
Tancredi, R.G.2
Lie, J.T.3
-
9
-
-
0028908094
-
The management of thrombosis in the antiphospholipid-antibody syndrome
-
Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332:993-997.
-
(1995)
N Engl J Med
, vol.332
, pp. 993-997
-
-
Khamashta, M.A.1
Cuadrado, M.J.2
Mujic, F.3
Taub, N.A.4
Hunt, B.J.5
Hughes, G.R.6
-
10
-
-
0030856433
-
Primary pulmonary hypertension: Improved long-term effects and survival with continuous intravenous epoprostenol infusion
-
Shapiro SM, Oudiz RJ, Cao T, et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol. 1997;30:343-349.
-
(1997)
J Am Coll Cardiol
, vol.30
, pp. 343-349
-
-
Shapiro, S.M.1
Oudiz, R.J.2
Cao, T.3
-
11
-
-
0033512182
-
Systemic sclerosis-associated pulmonary hypertension: Short- and long-term effects of epoprostenol (prostacyclin)
-
Klings ES, Hill NS, Ieong MH, Simms RW, Korn JH, Farber HW. Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin). Arthritis Rheum. 1999;42:2638-2645.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 2638-2645
-
-
Klings, E.S.1
Hill, N.S.2
Ieong, M.H.3
Simms, R.W.4
Korn, J.H.5
Farber, H.W.6
-
12
-
-
17144452827
-
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial
-
Badesch DB, Tapson VF, McGoon MD, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial. Ann Intern Med. 2000;132:425-434.
-
(2000)
Ann Intern Med
, vol.132
, pp. 425-434
-
-
Badesch, D.B.1
Tapson, V.F.2
McGoon, M.D.3
-
14
-
-
0033735604
-
Interstitial lung disease in polymyositis and dermatomyositis
-
Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2000;12:501-508.
-
(2000)
Curr Opin Rheumatol
, vol.12
, pp. 501-508
-
-
Hirakata, M.1
Nagai, S.2
-
15
-
-
0032937188
-
Interstitial lung disease in association with polymyositis-dermatomyositis: Long-term follow-up CT evaluation in seven patients
-
Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology. 1999;210:333-338.
-
(1999)
Radiology
, vol.210
, pp. 333-338
-
-
Akira, M.1
Hara, H.2
Sakatani, M.3
-
16
-
-
0031862360
-
Pulmonary involvement in polymyositis and in dermatomyositis
-
Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol. 1998;25:1336-1343.
-
(1998)
J Rheumatol
, vol.25
, pp. 1336-1343
-
-
Marie, I.1
Hatron, P.Y.2
Hachulla, E.3
Wallaert, B.4
Michon-Pasturel, U.5
Devulder, B.6
-
17
-
-
0027442306
-
Idiopathic inflammatory myopathy of the antisynthetase (Jo-1) type associated with noncaseating granulomas
-
Moder KG, Gaffey TA, Matteson EL. Idiopathic inflammatory myopathy of the antisynthetase (Jo-1) type associated with noncaseating granulomas. Arthritis Rheum. 1993;36:1743-1747.
-
(1993)
Arthritis Rheum
, vol.36
, pp. 1743-1747
-
-
Moder, K.G.1
Gaffey, T.A.2
Matteson, E.L.3
-
18
-
-
0016638734
-
Polymyositis and dermatomyositis (first of two parts)
-
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344-347.
-
(1975)
N Engl J Med
, vol.292
, pp. 344-347
-
-
Bohan, A.1
Peter, J.B.2
-
19
-
-
0026536572
-
Risk of cancer in patients with dermatomyositis or polymyositis: A population-based study
-
Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med. 1992;326:363-367.
-
(1992)
N Engl J Med
, vol.326
, pp. 363-367
-
-
Sigurgeirsson, B.1
Lindelof, B.2
Edhag, O.3
Allander, E.4
-
20
-
-
0028893167
-
Cancer risk following polymyositis and dermatomyositis: A nationwide cohort study in Denmark
-
Chow WH, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, Fraumeni JF Jr. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control. 1995;6:9-13.
-
(1995)
Cancer Causes Control
, vol.6
, pp. 9-13
-
-
Chow, W.H.1
Gridley, G.2
Mellemkjaer, L.3
McLaughlin, J.K.4
Olsen, J.H.5
Fraumeni Jr., J.F.6
-
21
-
-
0029056534
-
Elevated cancer incidence in patients with dermatomyositis: A population based study
-
Airio A, Pukkala E, Isomaki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol. 1995;22:1300-1303.
-
(1995)
J Rheumatol
, vol.22
, pp. 1300-1303
-
-
Airio, A.1
Pukkala, E.2
Isomaki, H.3
-
22
-
-
0035852478
-
Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study
-
Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96-100.
-
(2001)
Lancet
, vol.357
, pp. 96-100
-
-
Hill, C.L.1
Zhang, Y.2
Sigurgeirsson, B.3
-
23
-
-
0017702390
-
Acute dermatomyositis-polymyositis and malignancy
-
Talbott JH: Acute dermatomyositis-polymyositis and malignancy. Semin Arthritis Rheum. 1977;6:305-360.
-
(1977)
Semin Arthritis Rheum
, vol.6
, pp. 305-360
-
-
Talbott, J.H.1
-
24
-
-
0016786884
-
Amyloidosis associated with dermatomyositis and features of multiple myeloma: The progression of amyloidosis associated with corticosteroid and cytotoxic drug therapy
-
Zilko PJ, Dawkins RL. Amyloidosis associated with dermatomyositis and features of multiple myeloma: the progression of amyloidosis associated with corticosteroid and cytotoxic drug therapy. Am J Med. 1975;59:448-452.
-
(1975)
Am J Med
, vol.59
, pp. 448-452
-
-
Zilko, P.J.1
Dawkins, R.L.2
-
25
-
-
0037394106
-
Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma
-
Younis TH, Alam A, Paplham P, Spangenthal E, McCarthy P. Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma [letter] [published correction appears in Br J Haematol. 2003;123:563]. Br J Haematol. 2003;121:191-192.
-
(2003)
Br J Haematol
, vol.121
, pp. 191-192
-
-
Younis, T.H.1
Alam, A.2
Paplham, P.3
Spangenthal, E.4
McCarthy, P.5
-
26
-
-
0242266427
-
-
published correction appears
-
Younis TH, Alam A, Paplham P, Spangenthal E, McCarthy P. Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma [letter] [published correction appears in Br J Haematol. 2003;123:563]. Br J Haematol. 2003;121:191-192.
-
(2003)
Br J Haematol
, vol.123
, pp. 563
-
-
-
27
-
-
0031945938
-
Pulmonary hypertension in POEMS syndrome: A new feature mediated by cytokines
-
Lesprit P, Godeau B, Authier FJ, et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med. 1998;157(3, pt 1):907-911.
-
(1998)
Am J Respir Crit Care Med
, vol.157
, Issue.3 PART 1
, pp. 907-911
-
-
Lesprit, P.1
Godeau, B.2
Authier, F.J.3
-
28
-
-
0038526327
-
POEMS syndrome: Definitions and long-term outcome
-
Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496-2506.
-
(2003)
Blood
, vol.101
, pp. 2496-2506
-
-
Dispenzieri, A.1
Kyle, R.A.2
Lacy, M.Q.3
|